Clinical Trial Update: Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 48-hour infusions of an HNO donor for safety and efficacy in hospitalized heart failure patients has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• HNO (Nitroxyl) donor (nitroxyl donor)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2020-08-19